Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome
- PMID:16624293
- DOI: 10.1016/j.expneurol.2006.02.005
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome
Abstract
The Ts65Dn mouse, an adult model of Down syndrome displays behavioral deficits consistent with a dysfunctional hippocampus, similar to that seen with DS. In looking for mechanisms underlying these performance deficits, we have assessed adult neurogenesis in the dentate gyrus of Ts65Dn. Under untreated conditions, Ts65Dn mice (2-5 months old) showed markedly fewer BrdU-labeled cells than euploid animals. Chronic antidepressant treatment for over 3 weeks with the serotonin selective reuptake inhibitor, fluoxetine, increased neurogenesis in the Ts65Dn to comparable levels seen in the euploid by augmenting both proliferation and survival of BrdU-labeled cells in the subgranular layer and granule cell layer of the hippocampus, respectively.
Similar articles
- Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.Stagni F, Giacomini A, Guidi S, Ciani E, Ragazzi E, Filonzi M, De Iasio R, Rimondini R, Bartesaghi R.Stagni F, et al.Neurobiol Dis. 2015 Feb;74:204-18. doi: 10.1016/j.nbd.2014.12.005. Epub 2014 Dec 10.Neurobiol Dis. 2015.PMID:25497735
- Hippocampal hypocellularity in the Ts65Dn mouse originates early in development.Lorenzi HA, Reeves RH.Lorenzi HA, et al.Brain Res. 2006 Aug 9;1104(1):153-9. doi: 10.1016/j.brainres.2006.05.022. Epub 2006 Jul 7.Brain Res. 2006.PMID:16828061
- Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.Guidi S, Stagni F, Bianchi P, Ciani E, Ragazzi E, Trazzi S, Grossi G, Mangano C, Calzà L, Bartesaghi R.Guidi S, et al.Brain Pathol. 2013 Mar;23(2):129-43. doi: 10.1111/j.1750-3639.2012.00624.x. Epub 2012 Sep 3.Brain Pathol. 2013.PMID:22817700Free PMC article.
- Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders.David DJ, Wang J, Samuels BA, Rainer Q, David I, Gardier AM, Hen R.David DJ, et al.Neuroscientist. 2010 Oct;16(5):578-91. doi: 10.1177/1073858409360281.Neuroscientist. 2010.PMID:20889967Review.
- Alterations of brain circuits in Down syndrome murine models.Gotti S, Caricati E, Panzica G.Gotti S, et al.J Chem Neuroanat. 2011 Dec;42(4):317-26. doi: 10.1016/j.jchemneu.2011.09.002. Epub 2011 Sep 16.J Chem Neuroanat. 2011.PMID:21946025Review.
Cited by
- Prospects for improving brain function in individuals with Down syndrome.Costa AC, Scott-McKean JJ.Costa AC, et al.CNS Drugs. 2013 Sep;27(9):679-702. doi: 10.1007/s40263-013-0089-3.CNS Drugs. 2013.PMID:23821040Review.
- Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.Gardiner KJ.Gardiner KJ.Drug Des Devel Ther. 2014 Dec 17;9:103-25. doi: 10.2147/DDDT.S51476. eCollection 2015.Drug Des Devel Ther. 2014.PMID:25552901Free PMC article.Review.
- Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome.Chakrabarti L, Galdzicki Z, Haydar TF.Chakrabarti L, et al.J Neurosci. 2007 Oct 24;27(43):11483-95. doi: 10.1523/JNEUROSCI.3406-07.2007.J Neurosci. 2007.PMID:17959791Free PMC article.
- Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.López-Hidalgo R, Ballestín R, Vega J, Blasco-Ibáñez JM, Crespo C, Gilabert-Juan J, Nácher J, Varea E.López-Hidalgo R, et al.Front Neurosci. 2016 Mar 2;10:75. doi: 10.3389/fnins.2016.00075. eCollection 2016.Front Neurosci. 2016.PMID:26973453Free PMC article.
- Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.Kazim SF, Blanchard J, Bianchi R, Iqbal K.Kazim SF, et al.Sci Rep. 2017 Apr 3;7:45561. doi: 10.1038/srep45561.Sci Rep. 2017.PMID:28368015Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical